No Data
No Data
Cronos Group's Growth Hindered by Capacity Constraints and Market Limitations, Maintains Sell Rating
Cronos Group Reports Strong 2024 Financial Results
Cronos Group Earnings Call Highlights Growth and Challenges
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability
Earnings Call Summary | Cronos Group(CRON.US) Q4 2024 Earnings Conference
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap
Unlock the Full List